Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Langenbecks Arch Surg ; 393(1): 49-58, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17876601

ABSTRACT

BACKGROUND AND AIMS: Isolated tumor cells (ITCs) in cancer patients are retrieved mostly using immunohistochemistry with antibodies directed against antiepithelial antigens (for example Ber-EP4), which are supposed not to be present in metastatic-free tissue. To date, there has been ongoing controversy whether those cells have biologic significance and are linked with tumor progression and impaired patient's prognosis. Therefore, the aim of this study was to further characterize Ber-EP4-positive cells in various tissues, with special emphasis on their tumorigenic origin. MATERIALS AND METHODS: The frequency and prognostic impact of ITCs in lymph nodes displayed by means of monoclonal antibody Ber-EP4 were evaluated in retrospective (n = 292) and prospective (n = 100) collectives of various gastrointestinal carcinomas free of metastatic disease in conventional histopathology (pN0). Furthermore, the frequency of ITCs in the peritoneal cavity and bone marrow was analyzed in case of absence of overt distant metastasis (pM0) in the prospective collective. Ber-EP4-immunoreactive cells were further characterized for tumorigenic origin using morphological criteria and immunohistochemical double staining for Ber-EP4 and p53. RESULTS: Ber-EP4-positive cells could be revealed in lymph nodes in 44.3% of pN0-gastrointestinal carcinomas, in the peritoneal cavity in 19%, and in the bone marrow in 10%. In lymph nodes, BerEP4-immunoreactive cells exhibited a metastatic-atypical morphology in 59%; however, it was always typical for true tumor cells in the peritoneal cavity or bone marrow. The cumulative 5-year survival rate was adversely affected by Ber-EP4-immunoreactive cells in uni- and multivariate analysis, irrespective of the underlying cell morphology (68% for Ber-EP4 negative, 41% for Ber-EP4 positive with atypical and typical morphology each). In the case of a p53-positive primary tumor, 70% of the corresponding ITCs also overexpressed p53, while the remainder was deemed p53 negative (p = 0.002). CONCLUSION: ITCs detected by the antiepithelial antibody Ber-EP4 are present in a substantial proportion of apparently tumor-free lymph nodes. These cells impair patients' prognoses, irrespective of the underlying cell morphology. As approximately one third of Ber-EP4-positive cells in p53-positive primary tumors do not overexpress p53; their true tumorigenic origin needs to be further investigated.


Subject(s)
Gastrointestinal Neoplasms/pathology , Lymphatic Metastasis/pathology , Tumor Suppressor Protein p53/analysis , Adult , Aged , Aged, 80 and over , Antibodies, Monoclonal , Biomarkers, Tumor/immunology , Bone Marrow/pathology , Child , Colonic Neoplasms/mortality , Colonic Neoplasms/pathology , Colonic Neoplasms/surgery , Female , Gastrointestinal Neoplasms/mortality , Gastrointestinal Neoplasms/surgery , Humans , Immunoenzyme Techniques , Lymph Node Excision , Lymph Nodes/pathology , Male , Middle Aged , Neoplasm Staging , Pancreatic Neoplasms/mortality , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms/surgery , Peritoneum/pathology , Predictive Value of Tests , Prognosis , Prospective Studies , Retrospective Studies , Stomach Neoplasms/mortality , Stomach Neoplasms/pathology , Stomach Neoplasms/surgery , Survival Rate
2.
Chirurg ; 77(1): 76-8, 2006 Jan.
Article in German | MEDLINE | ID: mdl-16418877

ABSTRACT

Mesh wrapping hepatorrhaphy is an established method to control severe hepatic bleeding after trauma. Besides the multiple advantages of this technique, only a few complications are described in literature. We report a patient with severe liver trauma showing ischemia of the liver caused by post-traumatic edema and compression of the liver after mesh wrapping hepatorraphy to control the bleeding. To avoid this complication, early and frequent control of liver enzymes is highly recommended and, in case of elevation, laparotomy and decompression should be performed.


Subject(s)
Edema/surgery , Hemostasis, Surgical/methods , Ischemia/surgery , Liver Function Tests , Liver/blood supply , Liver/injuries , Liver/surgery , Multiple Trauma/surgery , Polyglactin 910 , Postoperative Complications/surgery , Surgical Mesh , Transaminases/blood , Wounds, Nonpenetrating/surgery , Adult , Angiography , Edema/diagnostic imaging , Female , Humans , Ischemia/diagnostic imaging , Multiple Trauma/diagnostic imaging , Postoperative Complications/diagnostic imaging , Reoperation , Rupture , Suture Techniques , Tomography, X-Ray Computed , Wounds, Nonpenetrating/diagnostic imaging
3.
Chirurg ; 76(11): 1064-72, 2005 Nov.
Article in German | MEDLINE | ID: mdl-15971035

ABSTRACT

PURPOSE: The aim of this study was to determine the frequency and effect on prognosis of occult tumor cells in regional lymph nodes judged to be tumor-free in conventional histopathology of pancreatic cancer patients. PATIENTS AND METHODS: Among 115 patients who underwent pancreatic resection for pancreatic (n=84) or distal common bile duct malignancy (n=12) or carcinoma of the papilla (n=19), 48 (42%) were staged pN0. Archival paraffin blocks of 271 resected regional lymph nodes of 41 pN0 patients were reevaluated for occult tumor cells using monoclonal antibody Ber-EP4. Cases with or without isolated tumor cells were compared regarding the distribution of various clinicopathological factors. RESULTS: Of 41 pN0 patients, 16 (39%) exhibited single Ber-Ep4 immunoreactive cells or small cell clusters in at least one lymph node. The occurrence of occult tumor cells was not dependent on other clinicopathological factors such as pT stage, grading, or curative resection. However, those cells were encountered more frequently in common bile duct carcinomas (100%) than in pancreatic (36%) or papilla (20%) carcinomas (P=0.009). Occult tumor cells impaired prognosis significantly in uni- and multivariate analyses (estimated 5-year survival 53% for pN0((i-)) vs 10% for pN0((i+)) and 9% for pN1/N2; P=0.0047). CONCLUSION: Occult tumor cells are frequent in apparently tumor-free lymph nodes of pancreatic cancer patients and often overlooked in conventional histopathology. They are encountered even in limited stages of disease and they impair prognosis, which is comparable to that of patients with true lymphatic metastases. Occult tumor cells in lymph nodes of pancreatic cancer patients could be used to stratify adjuvant therapy.


Subject(s)
Ampulla of Vater/surgery , Carcinoma, Ductal/surgery , Common Bile Duct Neoplasms/surgery , Lymph Node Excision , Lymphatic Metastasis/pathology , Pancreatectomy , Pancreatic Neoplasms/surgery , Aged , Ampulla of Vater/pathology , Carcinoma, Ductal/pathology , Common Bile Duct Neoplasms/pathology , Disease Progression , Female , Humans , Lymph Nodes/pathology , Male , Middle Aged , Neoplasm Staging , Pancreatic Neoplasms/pathology , Prognosis , Survival Analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...